News
25 de fevereiro de 2011 - Production of reagents for hematology analyzer to be newly undertaken
Existing plants to be consolidated into this core plant
15 de fevereiro de 2011 - Targeting 150 billion yen in net sales, operating income margin of 13% or more, and ROE of at least 11% in five years.
8 de fevereiro de 2011 - Production capacity of hematology reagents is to be doubled
Handle expansion in medical services driven by economic growth